Related Experiment Video
Updated: May 19, 2026

Generation and Isolation of Cell Cycle-arrested Cells with Complex Karyotypes
Published on: April 13, 2018
Reversine induces cell cycle arrest, polyploidy, and apoptosis in human breast cancer cells
Chin-Ho Kuo1, Yin-Che Lu, Ya-Shin Tseng
1Division of Hematology-Oncology and Blood Bank, Department of Internal Medicine, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi, Taiwan.
Background:
Reversine, a small synthetic purine analogue, has been reported to be effective in tumor suppression. In the present study, we demonstrated an antitumor activity of reversine that could suppress cellular proliferation and induce cell cycle arrest and apoptosis in human breast cancer cell lines.
Methods:
To evaluate whether reversine could suppress cell growth of MCF-7 and MDA-MB-231 cells and induce cell death, the cell viability, cell cycle, and apoptosis were determined in this study.
Results:
Reversine treatment in human breast cancer cells reduced cell viability in a dose-dependent manner. Cell cycle accumulation at the G2/M phase in reversine-treated cells was also determined. Moreover, polyploidy was also found in reversine-treated cells. Apoptosis in reversine-treated cells was exhibited with PARP cleavage and caspase-3 and caspase-8 activation, but not caspase-9 activation, indicating that caspase-dependent apoptosis mediated by an extrinsic pathway took place in reversine-treated cells. Furthermore, reversine attenuated cell death in cells pretreated with a pan-caspase inhibitor before reversine treatment.
Conclusions:
In the present study, we demonstrated that reversine contributes to growth inhibition in human breast cancer cells through cell cycle arrest, polyploidy, and/or apoptosis induction. The apoptosis mediated by reversine was induced by the mitochondria-independent pathway. Therefore, the potential role of reversine as a novel therapeutic agent for the treatment of breast cancer is worthy of further investigation.
Insights
Reversine, a synthetic purine analogue, effectively suppresses human breast cancer cell growth by inducing cell cycle arrest, polyploidy, and apoptosis. This compound shows promise as a novel therapeutic agent for breast cancer treatment.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Reversine, a synthetic purine analogue, exhibits known tumor suppressive properties.
- This study investigates reversine's specific antitumor effects on human breast cancer cell lines.
Purpose of the Study:
- To evaluate reversine's efficacy in suppressing proliferation and inducing cell death in human breast cancer cells.
- To elucidate the mechanisms underlying reversine's antitumor activity, including cell cycle regulation and apoptosis induction.
Main Methods:
- Assessed cell viability, cell cycle progression, and apoptosis in MCF-7 and MDA-MB-231 cells following reversine treatment.
- Analyzed key apoptosis markers such as PARP cleavage and caspase activation (caspase-3, -8, and -9).
- Investigated the role of the caspase-dependent extrinsic pathway in reversine-induced apoptosis.
Main Results:
- Reversine significantly reduced breast cancer cell viability in a dose-dependent manner.
- Observed cell cycle arrest at the G2/M phase and induction of polyploidy in reversine-treated cells.
- Demonstrated caspase-dependent apoptosis via the extrinsic pathway, evidenced by PARP cleavage and caspase-3/-8 activation, independent of caspase-9.
Conclusions:
- Reversine inhibits human breast cancer cell growth through cell cycle arrest, polyploidy, and apoptosis induction.
- The observed apoptosis is mediated by a mitochondria-independent pathway.
- Reversine warrants further investigation as a potential therapeutic agent for breast cancer.
More Related Videos
Related Concept Videos
Replicative Cell Senescence
Negative Regulator Molecules
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Inhibition of Cdk Activity
Inhibition of CDK Activity
DNA Damage Can Stall the Cell Cycle

